Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) GF Value Rank: 9 (As of Aug. 17, 2026) — 125% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
60 GF Score
Price NT$35.00
GF Value NT$40.11
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co GF Value Rank?

Chunghwa Chemical Synthesis & Biotech Co TPE:1762 -0.14% 60 GF Value Rank is 9 as of Aug. 17, 2026, which is 125% above its 10-year median of 4.00. GuruFocus rates TPE:1762 with a GF Score™ of 60/100 and a GF Value™ of NT$40.11 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Chunghwa Chemical Synthesis & Biotech Co has the GF Value Rank of 9.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Chunghwa Chemical Synthesis & Biotech Co GF Value Rank Related Terms


TPE:1762 vs VRTX, REGN, RVMD: GF Value Rank Comparison

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co GF Value Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank falls into.


TPE:1762
60GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 9 mean?
Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) has a GF Value Rank of 9 as of Aug. 17, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. This is 125% above median its historical median of 4.00. Over the past decade, Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank has ranged from 1.00 to 10.00.
Is Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank too high?
Chunghwa Chemical Synthesis & Biotech Co's current GF Value Rank of 9 is 125% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Chunghwa Chemical Synthesis & Biotech Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank compare to VRTX and REGN?
Chunghwa Chemical Synthesis & Biotech Co's GF Value Rank of 9 can be compared against companies in the Biotechnology industry. Historically, Chunghwa Chemical Synthesis & Biotech Co's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Biotechnology company?
A good GF Value Rank depends on the Biotechnology industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. Chunghwa Chemical Synthesis & Biotech Co's current GF Value Rank is 9, which is 125% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chunghwa Chemical Synthesis & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$40.11, compared to a current price of NT$35.00 — trading 12.7% below its estimated fair value. The current GF Value Rank is 9, which is 125% above median its 10-year median of 4.00. Chunghwa Chemical Synthesis & Biotech Co's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Chunghwa Chemical Synthesis & Biotech Co (TPE:1762), the current GF Value Rank is 9 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be undervalued. The current stock price of NT$35.00 is trading 12.7% below its estimated GF Value™ of NT$40.11. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Modestly Undervalued.

Key valuation signals for TPE:1762:

  • GF Value Rank: 9 (125% above median its 10-year median of 4.00)
  • GF Value™: NT$40.11 vs. price of NT$35.00 (12.7% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
60GF Score

Get the complete analysis for TPE:1762

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$35.00
Price
NT$40.11
GF Value